News
-
-
PRESS RELEASE
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
Immunic reports positive long-term data from phase 2 EMPhASIS Trial of Vidofludimus Calcium in relapsing-remitting multiple sclerosis, showing favorable safety & tolerability profile up to 5.5 years -
-
-
-
-
-
PRESS RELEASE
Correction of a release from 24/06/2025, 09:00 CET/CEST - Mountain Alliance aims to unlock new potential in defense tech
Mountain Alliance AG aims to unlock new potential in defense tech by investing in dual-use business models such as drone technology and cybersecurity. Strong defense expertise and dynamic market environment enhance portfolio diversification and exit capability -
PRESS RELEASE
Primary Hydrogen Commences Field Sampling Program at Dove Creek
Primary Hydrogen Corp. starts field sampling program at Dove Creek project in Colorado, USA, utilizing innovative techniques to minimize artificial hydrogen. Program aims to enhance exploration model and resource potential -